Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00483977 · ClinicalTrials.gov registry record · Phase 2
A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee
A Phase 2 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 2
- Development phase
- 113
- Enrollment target
NCT00483977 is a Phase 2 study that was terminated before completion, run by Pfizer. The registered enrollment target is 113 participants.
The verdict
NCT00483977, a Phase 2 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 113 participants
- Enrollment target
Study Summary
The primary aim is to assess if PF-00592379 is able to reduce pain in patients with osteoarthritis of the knee.
Interventions
- DRUG Placebo
- DRUG Oxycodone
- DRUG PF-000592379
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2007-06 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00483977
The ClinicalTrials.gov registry entry for NCT00483977 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00483977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00483977 about?
NCT00483977 is a clinical study titled "A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee". The primary aim is to assess if PF-00592379 is able to reduce pain in patients with osteoarthritis of the knee.
What is the current status of trial NCT00483977?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 113 participants. The study started on 2007-06. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00483977?
The interventions under investigation include: Placebo (DRUG), Oxycodone (DRUG), PF-000592379 (DRUG).
Who is sponsoring clinical trial NCT00483977?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.